Global Asparaginase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin's lymphoma. It is given by injection into a vein, muscle, or under the skin. A pegylated version is also available. Asparaginase was approved for medical use in the United States in 1978. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system.
Global Asparaginase key players include Jazz Pharmaceuticals, Servier Pharmaceuticals, Medac GmbH, Kyowa Hakko Kirin, Qianhong Bio-pharma, etc. Global top five manufacturers hold a share about 95%. Asia-Pacific is the largest market, with a share about 48%, followed by North America and Europe, both have a share about 35 percent. In terms of product, Pegylated is the largest segment. And in terms of application, the largest application is Acute Lymphoblastic Leukemia, followed by Acute Myeloid Leukemia, etc.

Market Analysis and Insights: Global Asparaginase Market
In 2020, the global Asparaginase market size was US$ 358 million and it is expected to reach US$ 398.2 million by the end of 2027, with a CAGR of 1.5% during 2021-2027.
Global Asparaginase Scope and Market Size
Asparaginase market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Asparaginase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.


Segment by Type, the Asparaginase market is segmented into
Escherichia Coli
Erwinia Chrysanthemi
Pegylated


Segment by Application, the Asparaginase market is segmented into
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape

and Asparaginase Market Share Analysis
Asparaginase market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Asparaginase product introduction, recent developments, Asparaginase sales by region, type, application and by sales channel.

The major companies include:
Jazz Pharmaceuticals
Servier Pharmaceuticals
Medac GmbH
Kyowa Hakko Kirin
Qianhong Bio-pharma
Taj Pharmaceuticals
Mingxing Pharma
SL Pharma
United Biotech